On December 6, Fosun Pharmaceutical stated on the investor interactive platform that the Forbitai BNT162b2, Forbitai bivalent vaccine, and Forbitai XBB.1.5 vaccine are currently sold in Hong Kong and Macao.
复星医药：复必泰BNT162b2、复必泰二价疫苗、复必泰XBB.1.5疫苗目前于港澳销售
Fosun Pharmaceuticals: Forbitai BNT162b2, Forbitai bivalent vaccine, and Forbitai XBB.1.5 vaccine are currently sold in Hong Kong and Macao
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.